SURPASS–CVOT (Follow-up)
The Effect of Tirzepatide versus Dulaglutide on Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes
- Medicine
- Tirzepatide
- Population
- Diabetes mellitus
- Phase
- III
- Starting year
- 2019
- More information
- Clinicaltrials.gov